Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Xoma reported $-10170000 in Operating Profit for its fiscal quarter ending in March of 2023.

Operating Profit Change
AbbVie ABBV:US USD 2.77B 2.73B
Agenus AGEN:US USD -54341000 5.35M
Agios Pharmaceuticals AGIO:US USD -90613000 119.29M
Ardelyx ARDX:US USD -26064000 38.21M
BioMarin Pharmaceutical BMRN:US USD 59.35M 83.85M
Bluebird Bio BLUE:US USD 8.44M 17M
Celldex Therapeutics CLDX:US USD -32471000 4.59M
Chimerix CMRX:US USD -24218000 404K
Curis CRIS:US USD -11627000 1.41M
Eli Lilly LLY:US USD 1.49B 342.4M
Emergent BioSolutions EBS:US USD -148100000 83M
Incyte Corp INCY:US USD 24.77M 45.32M
Intercept Pharmaceuticals ICPT:US USD -31632000 13.61M
Life Technologies LIFE:US USD -12787000 4.84M
MacroGenics MGNX:US USD -38426000 50.41M
Novartis NOVN:VX USD 2.86B 907M
Novartis NVS:US USD 2.86B 907M
Pfizer PFE:US USD 6.79B 1.62B
Prothena PRTA:US USD -56325000 56.25M
Regeneron Pharmaceuticals REGN:US USD 946.7M 200.1M
Xoma XOMA:US USD -10170000 3.96M